Provencio-Pulla, Mariano http://orcid.org/0000-0001-6315-7919
Pérez-Parente, Diego http://orcid.org/0000-0001-6436-2201
Olson, Sara http://orcid.org/0009-0001-9619-6065
Hasan, Haroon http://orcid.org/0000-0003-1943-9307
Balea, Begoña Campos http://orcid.org/0000-0002-8927-9129
Rodríguez-Abreu, Delvys http://orcid.org/0000-0003-0506-1366
Piqueras, Marta López-Brea http://orcid.org/0000-0002-3583-1889
Pal, Navdeep http://orcid.org/0000-0002-2013-8678
Wilkinson, Samantha http://orcid.org/0000-0003-3897-6968
Vilas, Esther http://orcid.org/0000-0002-8651-949X
Ruiz-Gracia, Pedro http://orcid.org/0009-0009-9255-4783
Cobo-Dols, Manuel http://orcid.org/0000-0003-3402-1144
Funding for this research was provided by:
Roche España
Article History
Received: 5 September 2023
Accepted: 26 November 2023
First Online: 6 January 2024
Declarations
:
: MPP: Advisory board (Roche, Merck, BMS, AstraZeneca, Lilly, Pfizer, Bayer, Amgen, Janssen, Takeda), Speaker (Roche, Merck, BMS, Takeda, Sanofi), Research grant (Roche, BMS, Takeda). BCB: Speaker (Roche, Merck, BMS, AstraZeneca, Sanofi), Travel/accommodation/expenses (Roche, BMS, Lilly, Pfizer, Boehringer). DRA: Advisory board (Roche, Merck, BMS, AstraZeneca, Pfizer, Boehringer, Takeda), Speaker (Roche, Merck, BMS, AstraZeneca, Boehringer, Takeda), Travel/accommodation/expenses (Roche, Merck, BMS, AstraZeneca). MLBP: Advisory board (Roche, Merck, BMS, Takeda), Speaker (Roche, Merck, BMS, AstraZeneca, Pfizer, Takeda). MCD: Advisory board (Roche, BMS, AstraZeneca, Boehringer), Travel/accommodation/expenses (Roche, BMS, AstraZeneca). DPP, SO, HH, NPl, SW, EV, and PRG are Roche Farma SA employees.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.